Impact of electric cardioversion on platelet activation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00019949

Enrollment

Registered

2019-12-19

Start date

2015-04-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I48.0

Interventions

Group 1: Before elective cardioversion blood is drawn (aprox. 6 ml) and analyses (FACS, Aggregation measurement) are performed immediately. A second sample is drawn 1 hour after cardioversion and ana

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Atrial fibrillation

Exclusion criteria

Exclusion criteria: anti platelet drugs

Design outcomes

Secondary

Measure	Time frame
p-Selektin (platelet surface marker) Parameter of platelet aggregation measurement (AUC)	—

Primary

Measure	Time frame
PAC-1 (platelet surface marker) measured with FACS	—

Countries

Austria

Contacts

Public ContactHarald Haidl

Medizinische Universität Graz Univ. Klinik f. Kinder- und Jugendheilkunde Klinische Abteilung für Allgemeinpädiatrie

harald.haidl@medunigraz.at+4331638530008

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026